Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
46.48
+2.30 (5.21%)
At close: Mar 4, 2026, 4:00 PM EST
46.48
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:27 PM EST
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $2.24 billion as of March 4, 2026. Its market cap has increased by 325.75% in one year.
Market Cap
2.24B
Enterprise Value
1.84B
1-Year Change
325.75%
Ranking
Category
Stock Price
$46.48
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $2.24B, an increase of 226.40%. That is a compound annual growth rate of 197.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.13B | 6.64% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.34B |
| Mineralys Therapeutics | 2.26B |
| Telix Pharmaceuticals | 2.25B |
| Galapagos NV | 2.17B |
| Ultragenyx Pharmaceutical | 2.13B |
| Zai Lab | 1.99B |
| Ascentage Pharma Group International | 1.96B |
| Soleno Therapeutics | 1.95B |